Dr Reddys Laboratories (RDY) Current Assets (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Current Assets of $3.2 billion for Q2 2026, down 4.29% on a QoQ basis from $3.3 billion in Q1 2026, and little changed year-over-year from $3.2 billion in Q2 2025.
Analysis
Dr Reddys Laboratories (RDY) Current Assets (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported Current Assets for 18 years, with the latest figure at $3.2 billion in Q2 2026.
- On a quarterly basis, Current Assets changed 0.26% year-over-year to $3.2 billion in Q2 2026; TTM through Jun 2026 was $3.2 billion, a 0.26% change from a year earlier, with the FY2026 full-year figure at $3.2 billion, up 9.94% from the prior year.
- Current Assets was $3.2 billion for Q2 2026 at Dr Reddys Laboratories, down from $3.3 billion in the prior quarter.
- The five-year high for Current Assets was $3.3 billion in Q4 2025, with the low at $2.2 billion in Q3 2022.
- Average Current Assets over 5 years is $2.8 billion, with a median of $2.9 billion recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: Current Assets increased 26.09% in 2024, then fell 3.3% in 2025.
- Over 5 years, Current Assets stood at $2.4 billion in 2022, then advanced by 20.91% to $2.9 billion in 2023, then climbed by 4.63% to $3.0 billion in 2024, then increased by 11.5% to $3.3 billion in 2025, then slipped by 5.37% to $3.2 billion in 2026.
- The last three Current Assets figures came in at $3.2 billion (Q2 2026), $3.3 billion (Q1 2026), and $3.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 13.76 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 10.06 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 3.16 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 1.95 Bn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 6.52 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 544.97 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 825.43 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 630.95 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 72.50 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | 6.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.16 Bn |
| Mar 31, 2026 | 3.30 Bn |
| Dec 31, 2025 | 3.34 Bn |
| Sep 30, 2025 | 3.20 Bn |
| Jun 30, 2025 | 3.15 Bn |
| Mar 31, 2025 | 2.89 Bn |
| Dec 31, 2024 | 3.00 Bn |
| Sep 30, 2024 | 2.96 Bn |
| Jun 30, 2024 | 3.23 Bn |
| Mar 31, 2024 | 2.99 Bn |
| Dec 31, 2023 | 2.86 Bn |
| Sep 30, 2023 | 2.63 Bn |
| Jun 30, 2023 | 2.56 Bn |
| Mar 31, 2023 | 2.48 Bn |
| Dec 31, 2022 | 2.37 Bn |
| Sep 30, 2022 | 2.20 Bn |
| Jun 30, 2022 | 2.33 Bn |
| Mar 31, 2022 | 2.42 Bn |
| Dec 31, 2021 | 2.23 Bn |
| Sep 30, 2021 | 2.20 Bn |